Quynh-Nhu Nguyen, M.D., M.H.C.M.
Department of Thoracic Radiation Oncology, Division of Radiation Oncology
About Dr. Nguyen
Dr. Nguyen's clinical research efforts have combined both her interests in technology and value based outcomes to answer important clinical questions to continually improve patient care. Her training and experience in advanced technology including stereotactic body radiation therapy for prostate cancer, pulmonary metastases, liver metastases, adrenal metastases and osseous metastases have allowed her to focus her research interests in evaluating the optimal dose fractionation and SBRT techniques for improved clinical outcomes. Dr. Nguyen is also involved in particle therapy research reporting the long term outcomes for patients treated with proton therapy for thoracic and base of skull tumors. Her goal is to continue opening prospective clinical trials involving advanced technology to effectively improve patient outcomes.
Read More
Present Title & Affiliation
Primary Appointment
Associate Chief of Patience Experience, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Medical Director, AskMD Anderson, The University of Texas MD Anderson Cancer Center, Houston, TX
Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Clinical Medical Director (CMD) of Main Center, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Director of SBRT (ACB), Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
MDACC Network Clinical Liaison for Genitourinary Malignancies, MDACC Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX
MDACC Network Clinical Liaison for Thoracic Malignancies, MDACC Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX
Dual/Joint/Adjunct Appointment
Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
Education & Training
Degree-Granting Education
| 2021 | The Harvard University T.H. Chan School of Public Health, Cambridge, Massachusetts, US, Master in Healthcare Management, MHCM |
| 2001 | The George Washington University School of Medicine, Washington, DC, US, MD |
| 1997 | University of California at Irvine, Irvine, California, US, Biological Sciences, BS |
Postgraduate Training
| 2016-2016 | Certificate, Lean, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2012-2012 | Certificate, Leksell Gamma Knife Perfexion Introductory Training, Cleveland Clinic Department of Radiation Oncology, Cleveland, Ohio |
| 2012-2012 | Certificate, Clinical Safety and Effectiveness, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2007-2008 | Proton Radiotherapy and Stereotactic Radiosurgery Fellowship-PGY6, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2004-2004 | Proton Radiation Therapy Rotation, Department of Radiation Oncology, The Loma Linda University Medical Center, Loma Linda, California |
| 2003-2007 | Clinical Residency, Department of Radiation Oncology, The University of Virginia, Charlottesville, Virginia |
| 2003-2003 | Pediatric Rotation, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas |
| 2002-2003 | Research Fellowship, Department of Pathology, The University of Virginia, Charlottesville, Virginia |
| 2001-2002 | Clinical Internship, Department of Obstetrics and Gynecology, The Loma Linda University Medical Center, Loma Linda, California |
Board Certifications
| 2008 | The American Board of Radiology |
Experience & Service
Academic Appointments
Associate Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2021
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2012 - 2015
Assistant Professor, Department of Radiation Oncology, University of Southern California Keck School of Medicine, Los Angeles, CA, 2012 - 2012
Assistant Professor, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2008 - 2012
Student Researcher, Department of Radiation Oncology - Research, The University of Texas M.D. Anderson Cancer Center, Houston, TX, 2000 - 2000
Researcher and Coordinator, Department of Pediatrics - Research, The University of California at Irvine, Irvine, CA, 1994 - 1997
Administrative Appointments/Responsibilities
Clinical Medical Director (CMD) of Main Center, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Associate Clinical Medical Director (AMD), Genitourinary Center, Institutional Leadership Position, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - 2024
Division of Radiation Oncology Emergency Ride Out Team, The University of Texas MD Anderson Cancer Center, Houston, TX, 2019 - Present
Chair, eTDABC Working Group, Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present
Director of SBRT (ACB), Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - Present
Director of Research for MDACC Network and HALs, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2019
Cooper MD Anderson Thoracic Radiation Oncology Representative, MDACC Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, 2015 - 2016
Program Developer, Department of Radiation Oncology, MDACC Proton Therapy Melanoma and Sarcoma Base of Skull and Soft Tissue Malignancy Program, Houston, TX, 2014 - 2017
Clinical Medical Director, Department of Radiation Oncology, USC, Los Angeles, CA, 2012 - 2012
Clerkship Director, Department of Radiation Oncology, USC, Los Angeles, CA, 2012 - 2012
Other Appointments/Responsibilities
Board Member, Center for Goal Concordant Care Research, The University of Texas MD Anderson Cancer Center, Houston, TX, 2024 - Present
Associate Chief of Patience Experience, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Medical Director, AskMD Anderson, The University of Texas MD Anderson Cancer Center, Houston, TX, 2023 - Present
Institutional Tiered Readiness Briefing, The University of Texas MD Anderson Cancer Center, Houston, TX, 2020 - 2021
Collaboration with ICCI Value Based Working Group, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present
Director of Research for MDACC Network and HALs, The University of Texas MD Anderson Cancer Center, Houston, TX, 2017 - 2019
Education Committee Lung Session, Committee Member, American Society for Radiation Oncology (ASTRO), Arlington, VA, 2016 - Present
Cooper MD Anderson Relations Committee, MDACC Global, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - 2018
Team member, MDACC Proton Therapy Center Expansion and Business Development Team, Houston, TX, 2014 - Present
MDACC Network Clinical Liaison for Thoracic Malignancies, MDACC Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
MDACC Network Clinical Liaison for Genitourinary Malignancies, MDACC Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, 2014 - Present
Institutional Committee Activities
Committee Member, MDA Grievance Committee, 2023 - Present
Committee Member, Thoracic Cancer Multidisciplinary Tumor Board - Planning Committee, 2023 - Present
Committee Member, Vizient Analytics Working Group, ICCI, 2020 - Present
Representative, Faculty Senate, 2015 - 2021
Committee Member, Oncology Expert advisory Committee (OEA), Lung MRTX, 2014 - 2018
Fellowship Interview Committee, Department Radiation Oncology, 2014 - Present
Committee Member, Clinical Research Committee (CRC) #3, 2014 - 2018
Committee Member, MDACC Network: MD Anderson at Cooper Relationship Committee, 2014 - 2017
Committee Member, MDACC Skull Base Multidisciplinary Tumor Program, 2014 - Present
Sub-Committee Member, Clinical Effectiveness Sub-Committee of Medical Affairs Meeting, 2013 - 2017
Representative, Global: MD Anderson Cooper Thoracic Radiation Oncology Representative, 2013 - 2018
Director, Director of Medical Student Clerkship at the University of Southern California Keck School of Medicine, 2012 - 2012
Clinical Director of Operations, Clinical Director of Operations University of Southern California Keck/Norris Cancer Center, 2012 - 2012
Principal Investigator, RTOG Institution, 2012 - 2012
Honors & Awards
| Golden Key Honor Society, The University of California at Irvine | |
| Irvine Women's Club Scholarship, The University of California at Irvine | |
| Phi Beta Kappa Honor Society, The University of California at Irvine | |
| Kane-King-Dodek Obstetrical Honor Society, The George Washington University School of Medicine | |
| Resident Teaching Award, USC Keck Norris Cancer Center/LA County Hospital | |
| Fellow of ASTRO, Class of 2024, American Society for Radiation Oncology (ASTRO) |
Professional Memberships
Selected Publications
Peer-Reviewed Articles
- Hu Y, Paris S, Sahoo N, Wang Q, Wang Q, Barsoumian HB, Huang A, Da Silva J, Bienassis C, Leyton CSK, Voss TA, Masrorpour F, Riad T, Leuschner C, Puebla-Osorio N, Gandhi S, Nguyen QN, Wang J, Cortez MA, Welsh JW. Superior antitumor immune response achieved with proton over photon immunoradiotherapy is amplified by the nanoradioenhancer NBTXR3. J Nanobiotechnology 22(1):597, 2024. PMID: 39354474.
- Alcorn S, ÁA C, Bradfield L, Brennan M, Dennis K, Diaz DA, Doung YC, Elmore S, Hertan L, Johnstone C, Jones J, Larrier N, Lo SS, Nguyen QN, Tseng YD, Yerramilli D, Zaky S, Balboni T. External Beam Radiation Therapy for Palliation of Symptomatic Bone Metastases: An ASTRO Clinical Practice Guideline. Pract Radiat Oncol 14(5):377-397, 2024. e-Pub 2024. PMID: 38788923.
- Sosa, A, Rooney, MK, Thames, HD, Sanders, JW, Swanson, DM, Choi, S, Nguyen, QN, Mok, H, Kuban, DA, Ron Zhu, X, Shah, SJ, Mayo, LL, Hoffman, K, Tang, C, McGuire, SE, Sahoo, N, Zhang, X, Lee, AK, Pugh, T, Mahmood, U, Davis, JW, Chapin, BF, Corn, P, Kudchadker, R, Ausat, N, Frank, SJ. Proton therapy toxicity outcomes for localized prostate cancer. Clin Transl Radiat Oncol 48, 2024. PMID: 39188999.
- Weng J, Mesko S, Chronowski G, Lee P, Choi S, Das P, Koong AC, French K, Aloia T, Ehlers R, Elrod-Joplin D, Kerr A, Smith R, Martinez W, Bloom E, Shah SJ, Ning MS, Liao Z, Herman J, Moningi S, Moreno AC, Nguyen QN. Optimizing Outpatient Radiation Oncology Consult Workflow by Using Time-Driven Activity-Based Costing: Efficiency and Financial Impacts. JCO Oncol Pract 20(5):732-738, 2024. e-Pub 2024. PMID: 38330252.
- Corrigan KL, Xu T, Sasaki Y, Lin R, Chen AB, Welsh JW, Lin SH, Chang JY, Ning MS, Gandhi S, O'Reilly MS, Gay CM, Altan M, Lu C, Cascone T, Koutroumpakis E, Sheshadri A, Zhang X, Liao L, Zhu XR, Heymach JV, Nguyen QN, Liao Z. Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma. Radiother Oncol 193:110121, 2024. e-Pub 2024. PMID: 38311031.
- Burgess L, Nguyen E, Tseng CL, Guckenberger M, Lo SS, Zhang B, Nielsen M, Maralani P, Nguyen QN, Sahgal A. Practice and principles of stereotactic body radiation therapy for spine and non-spine bone metastases. Clin Transl Radiat Oncol 45:100716, 2024. e-Pub 2023. PMID: 38226025.
- Farooqi AS, Yoder AK, Lin HY, Pasalic D, Erasmus J, Betancourt S, Wernz C, Mitra D, Zarzour MA, Somaiah N, Conley A, Ratan R, Livingston A, Araujo DM, Roland C, Scally C, Keung E, Gandhi SN, Ashleigh Guadagnolo B, Nguyen QN, Bishop AJ. Stereotactic ablative radiation therapy for sarcoma lung metastases: indications for treatment and guidance for patient selection. Int J Radiat Oncol Biol Phys 118(4):971-978, 2024. e-Pub 2023. PMID: 37914142.
- Wang, L, Sanders, JW, Ward, JF, Lee, SR, Poenisch, F, Swanson, DM, Sahoo, N, Zhu, XR, Ma, J, Kudchadker, RJ, Choi, S, Nguyen, QN, Mayo, LL, Shah, SJ, Frank, SJ. A Novel Polymer-Encapsulated Multi-Imaging Modality Fiducial Marker with Positive Signal Contrast for Image-Guided Radiation Therapy. Cancers 16(3), 2024. PMID: 38339376.
- Sosa AJ, Thames HD, Sanders JW, Choi SL, Nguyen QN, Mok H, Ron Zhu X, Shah S, Mayo LL, Hoffman KE, Tang C, Lee AK, Pugh TJ, Kudchadker R, Frank SJ. Proton Therapy for the Management of Localized Prostate Cancer: Long-Term Clinical Outcomes at a Comprehensive Cancer Center. Radiother Oncol 188:109854, 2023. e-Pub 2023. PMID: 37597805.
- Navarro-Domenech I, Behroozian T, Hoskin P, Johnstone C, Recht A, Menten J, Oldenburger E, van der Linden YM, van der Velden JM, Nguyen QN, Simone CB, Johnstone P, Lutz S, Milton L, Andratschke N, Willmann J, Kazmierska J, Spalek M, Marta GN, Chow E, Raman S. Addressing concerns and uncertainties surrounding the application of palliative radiotherapy in cases with a 30-day expected mortality. Ann Palliat Med. e-Pub 2023. PMID: 37953216.
- Andring LM, Abu-Gheida I, Bathala T, Yoder AK, Manzar GS, Maldonado JA, Frank SJ, Choi S, Nguyen QN, Hoffman K, McGuire SE, Mok H, Aparicio A, Chapin BF, Tang C. Definitive local therapy for T4 prostate cancer associated with improved local control and survival. BJU Int 132(3):307-313, 2023. e-Pub 2023. PMID: 37057728.
- Hu Y, Paris S, Sahoo N, Bertolet G, Wang Q, Wang Q, Barsoumian HB, Da Silva J, Huang A, Doss DJ, Pollock DP, Hsu E, Selene N, Leyton CSK, Voss TA, Masrorpour F, Ganjoo S, Leuschner C, Pietz JT, Puebla-Osorio N, Gandhi S, Nguyen QN, Wang J, Cortez MA, Welsh JW. Nanoparticle-enhanced proton beam immunoradiotherapy drives immune activation and durable tumor rejection. JCI Insight 8(12), 2023. e-Pub 2023. PMID: 37345658.
- He K, Hong DS, Tang C, Sezen D, Cox L, Maleki A, Bertolet G, Nguyen QN, Comeaux NI, Schuda L, Chen D, Welsh JW. Five-Year Overall Survival with Ipilimumab and Stereotactic Ablative Radiotherapy for Metastatic Disease. Radiother Oncol 183:109618, 2023. e-Pub 2023. PMID: 36921766.
- Wong HCY, Chan AW, Johnstone P, Simone CB, Navarro-Domenech I, Hoskin P, Johnstone C, Recht A, Menten J, van der Linden YM, van der Velden JM, Nguyen QN, Lutz S, Andratschke N, Wilmann J, Kazmierska J, Spalek M, Lim F, Yu HM, Perez B, Marta GN, Vassiliou V, Lee SF, Bonomo P, Rembielak A, Chow E, Oldenburger E, Raman S. A critical appraisal of the four systematic reviews and meta- analysis on stereotactic body radiation therapy versus external beam radiotherapy for painful bone metastases and where we go from here. Ann Palliat Med. e-Pub 2023. PMID: 37303218.
- Navarro-Domenech I, Behroozian T, Hoskin P, Johnstone C, Recht A, Menten J, Oldenburger E, van der Linden YM, van der Velden JM, Nguyen QN, Simone CB, Johnstone P, Lutz S, Milton L, Andratschke N, Willmann J, Kazmierska J, Spalek M, Marta GN, Chow E, Raman S. Appropriateness of the 30-day expected mortality metric in palliative radiation treatment: a narrative review. Ann Palliat Med 12(3):620-632, 2023. e-Pub 2023. PMID: 37081704.
- Geng H, Liao Z, Nguyen QN, Berman AT, Robinson C, Wu A, Nichols RC, Willers H, Mohammed N, Mohindra P, Xiao Y. Implementation of Machine Learning Models to Ensure Radiotherapy Quality for Multicenter Clinical Trials: Report from a Phase III Lung Cancer Study. Cancers (Basel) 15(4), 2023. e-Pub 2023. PMID: 36831358.
- Vassilakopoulou M, H-C C, Wang X, Harada K, Iwatsuki M, Das P, Blum Murphy M, Matamoros, Jr A, Sagebiel T, Devine C, Thomas I, Sanders EM, Shanbhag N, Rogers JE, Lee JH, Weston B, Bhutani MS, Hofstetter W, Nguyen QN, Badgwell BD, Ajani JA. Localized gastroesophageal adenocarcinoma in the elderly: is age a factor associated with suboptimal treatment?. Oncology 101(3):153-158, 2023. e-Pub 2022. PMID: 36412619.
- Mesko S, Weng J, Das P, Koong AC, Herman JM, Elrod-Joplin D, Kerr A, Aloia T, Frenzel J, French KE, Martinez W, Recinos I, Alshaikh A, Daftary U, Moreno AC, Nguyen QN. Using patient flow analysis with real-time patient tracking to optimize radiation oncology consultation visits. BMC Health Serv Res 22(1):1517, 2022. e-Pub 2022. PMID: 36514109.
- Xu T, Wu L, Gandhi S, Jing W, Nguyen QN, Chen A, Chang JY, Nurieva R, Sheshadri A, Altan M, Lee PP, Lin SH, Liao Z. Treatment Related Pulmonary Adverse Events Induced by Chemoradiation and Durvalumab Affect Survival in Locally Advanced Non-Small Cell Lung Cancer. Radiother Oncol 176:149-156, 2022. e-Pub 2022. PMID: 36209942.
- Hu Y, Paris S, Bertolet G, Barsoumian HB, He K, Sezen D, Chen D, Wasley M, Silva JD, Mitchell JA, Voss TA, Masrorpour F, Leyton CK, Yang L, Leuschner C, Puebla-Osorio N, Gandhi S, Nguyen QN, Cortez MA, Welsh JW. Combining a nanoparticle-mediated immunoradiotherapy with dual blockade of LAG3 and TIGIT improves the treatment efficacy in anti-PD1 resistant lung cancer. J Nanobiotechnology 20(1):417, 2022. e-Pub 2022. PMID: 36123677.
- Behroozian T, Navarro I, Hoskin P, Johnstone C, Recht A, Menten J, Oldenburger E, van der Linden Y, van der Velden JM, Nguyen QN, Simone CB, Johnstone P, Lutz S, Milton L, Andratschke N, Willmann J, Kazmierska J, Spalek M, Chow E, Raman S. Update on the systematic review/meta-analysis of uncomplicated bone metastases treated with external beam radiation. Radiother Oncol 174:109-110, 2022. e-Pub 2022. PMID: 35850265.
- Chen M, Wang Z, Jiang S, Sun J, Wang L, Sahoo N, Gunn GB, Frank SJ, Xu C, Chen J, Nguyen QN, Chang JY, Liao Z, Ronald Zhu X, Zhang X. Predictive performance of different NTCP techniques for radiation-induced esophagitis in NSCLC patients receiving proton radiotherapy. Sci Rep 12(1):9178, 2022. e-Pub 2022. PMID: 35655073.
- De B, Venkatesan AM, Msaouel P, Ghia AJ, Li J, Yeboa DN, Nguyen QN, Bishop AJ, Jonasch E, Shah AY, Campbell MT, Wang J, Zurita-Saavedra AJ, Karam JA, Wood CG, Matin SF, Tannir NM, Tang C. Definitive Radiotherapy for Extracranial Oligoprogressive Metastatic Renal Cell Carcinoma as a Strategy to Defer Systemic Therapy Escalation. BJU Int 129(5):610-620, 2022. e-Pub 2021. PMID: 34228889.
- De B, Fu S, Chen YS, Das P, Ku K, Maroongroge S, Woodhouse KD, Hoffman KE, Nguyen QN, Reed VK, Chen AB, Koong AC, Smith BD, Smith GL. Patient, physician, and policy factors underlying variation in use of telemedicine for radiation oncology cancer care. Cancer Med 11(10):2096-2105, 2022. e-Pub 2022. PMID: 35297210.
- Lin SH, Lin HY, Verma V, Xu-Welliver M, Thall PF, Yao L, Kim PY, Gombos DS, Kawedia JD, Komaki R, Gomez DR, Nguyen QN, O'Reilly MS, Lu C, Fossella FV, Skoulidis F, Zhang J, Tsao AS, Heymach JV, Blumenschein GR. Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer. Cancer Treat Res Commun 30:100514, 2022. e-Pub 2022. PMID: 35051703.
- Hu Y, Paris S, Bertolet G, Barsoumian HB, Wang Q, Da Silva J, Patel NB, Nguyen N, Doss DJ, Huang A, Hsu E, Leyton CSK, Voss TA, Masrorpour F, Leuschner C, Pietz JT, Puebla-Osorio N, Gandhi S, Nguyen QN, Wang J, Cortez MA, Welsh JW. NBTXR3 improves the efficacy of immunoradiotherapy combining nonfucosylated anti-CTLA4 in an anti-PD1 resistant lung cancer model. Front Immunol 13:1022011, 2022. e-Pub 2022. PMID: 36405757.
- Tang C, Msaouel P, Hara K, Choi H, Le V, Shah AY, Wang J, Jonasch E, Choi S, Nguyen QN, Das P, Prajapati S, Yu Z, Khan K, Powell S, Murthy R, Sircar K, Tannir NM. Definitive radiotherapy in lieu of systemic therapy for oligometastatic renal cell carcinoma: a single-arm, single-centre, feasibility, phase 2 trial. Lancet Oncol 22(12):1732-1739, 2021. e-Pub 2021. PMID: 34717797.
- Hu Y, Paris S, Barsoumian H, Abana CO, He K, Sezen D, Wasley M, Masrorpour F, Chen D, Yang L, Dunn JD, Gandhi S, Nguyen QN, Cortez MA, Welsh JW. A radioenhancing nanoparticle mediated immunoradiation improves survival and generates long-term antitumor immune memory in an anti-PD1-resistant murine lung cancer model. J Nanobiotechnology 19(1):416, 2021. e-Pub 2021. PMID: 34895262.
- Hu Y, Paris S, Barsoumian H, Abana CO, He K, Wasley M, Younes AI, Masrorpour F, Chen D, Yang L, Dunn JD, Zhang J, Gandhi S, Nguyen QN, Cortez MA, Welsh J. Radiotherapy enhanced by NBTXR3 nanoparticles overcomes anti-PD1 resistance and evokes abscopal effects. Int J Radiat Oncol Biol Phys 111(3):647-657, 2021. e-Pub 2021. PMID: 34242713.
- Chang JY, Mehran RJ, Feng L, Verma V, Liao Z, Welsh JW, Lin SH, O'Reilly MS, Jeter MD, Balter PA, McRae SE, Berry D, Heymach JV, Roth JA, Trials Group SLC, Nguyen QN. Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery. Lancet Oncol 22(10):1448-1457, 2021. e-Pub 2021. PMID: 34529930.
- Nguyen QN. Errors in Reported Primary and Secondary Outcomes and Table Numbers in a Trial of Radiotherapy for Pain Relief in Patients With Bone Metastases. JAMA Oncol 7(10):1576-1577, 2021. e-Pub 2021. PMID: 34383007.
- Boyce-Fappiano D, Nguyen QN, Chapman BV, Allen PK, Gjyshi O, Pezzi TA, De B, Gomez D, Lin SH, Chang JY, Liao Z, Lee P, Gandhi SJ. Single Institution Experience of Proton and Photon-based Postoperative Radiation Therapy for Non-small-cell Lung Cancer. Clin Lung Cancer 22(5):e745-e755, 2021. e-Pub 2021. PMID: 33707003.
- Patel RR, He K, Barsoumian HB, Chang JY, Tang C, Verma V, Comeaux N, Chun SG, Gandhi S, Truong MT, Erasmus JJ, Hong DS, Lee PP, Ning MS, Nguyen QN, Heymach JV, Altan M, Blumenschein G, Fossella FV, Sezen D, Chen D, Carter BW, Davies MA, Glitza IC, Diab A, Ferrarotto R, Cabanillas ME, Yuan Y, Shah SJ, Parra ER, Sun B, Cortez MA, Welsh JW. High-dose irradiation in combination with non-ablative low-dose radiation to treat metastatic disease after progression on immunotherapy: results of a phase II trial. Radiother Oncol 162:60-67, 2021. e-Pub 2021. PMID: 34237343.
- WSME T, Chen D, Verma V, Hobbs BP, Peulen HMU, JGJV A, Bahce I, Niemeijer ALN, Chang JY, de Groot PM, Nguyen QN, Comeaux NI, Simon GR, Skoulidis F, Lin SH, He K, Patel R, Heymach J, Baas P, Welsh JW. Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials. Lancet Respir Med 9(5):467-475, 2021. e-Pub 2020. PMID: 33096027.
- Jing W, Liu Y, Zhu H, Welsh J, Gandhi S, Jeter M, Nguyen QN, Chen AB, O'Reilly M, Liao Z, Chang JY, Lee P, Lin SH. Prognosis of severe lymphopenia after postoperative radiotherapy in non-small cell lung cancer: Results of a long-term follow up study. Clin Transl Radiat Oncol 28:54-61, 2021. e-Pub 2021. PMID: 33778173.
- Grant SR, Smith BD, Colbert LE, Nguyen QN, Yu JB, Lin SH, Chen AB. National Quality Measure Compliance for Palliative Bone Radiation Among Patients With Metastatic Non-Small Cell Lung Cancer. J Natl Compr Canc Netw 26(13):1-6, 2021. e-Pub 2021. PMID: 34044365.
- Ajani JA, Harada K, Hwang H, Wang X, Abdelhakeem, AAF, Iwatsuki M, Blum Murphy M, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag ND, Zhao M, Bhutani M, Nguyen QN, Swisher SG, Ikoma N, Badgwell BD, Hofstetter WL. Frequency and Implications of paratracheal lymph node metastases in resectable esophageal or gastroesophageal junction adenocarcinoma. Ann Surg 273(4):751-757, 2021. e-Pub 2019. PMID: 31188215.
- Gjyshi O, Xu T, Elhammali A, Boyce-Fappiano D, Chun SG, Gandhi S, Lee P, Chen AB, Lin SH, Chang JY, Tsao A, Gay CM, Zhu XR, Zhang X, Heymach JV, Fossella FV, Lu C, Nguyen QN, Liao Z. Toxicity and Survival After Intensity-Modulated Proton Therapy Versus Passive Scattering Proton Therapy for NSCLC. J Thorac Oncol 16(2):269-277, 2021. e-Pub 2020. PMID: 33198942.
- Reichard CA, Kukreja J, Gregg JR, Bathala TK, Achim MF, Wang X, Davis JW, Nguyen QN, Chapin BF. Prediction of Organ-confined Disease in High- and Very-high-risk Prostate Cancer Patients Staged with Magnetic Resonance Imaging: Implications for Clinical Trial Design. Eur Urol Focus 7(1):71-77, 2021. e-Pub 2019. PMID: 31076357.
- Welsh JW, Heymach JV, Guo C, Menon H, Klein K, Cushman TR, Verma V, Hess KR, Shroff G, Tang C, Skoulidis F, Jeter M, Comeaux N, Patel RR, Chen D, Ozgen T, Nguyen QN, Chang JY, Altan M, Zhang J, Papadimitrakopoulou VA, Simon GR, Byers LA, Glisson B. Phase I/II Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage Small Cell Lung Cancer. J Thorac Oncol 15(12):1919-1927, 2020. e-Pub 2020. PMID: 32916308.
- Welsh J, Menon H, Chen D, Verma V, Tang C, Altan M, Hess K, de Groot P, Nguyen QN, Varghese R, Comeaux NI, Simon G, Skoulidis F, Chang JY, Papdimitrakopoulou V, Lin SH, Heymach JV. Pembrolizumab with or without radiation therapy for metastatic non-small cell lung cancer: a randomized phase I/II trial. J Immunother Cancer 8(2), 2020. PMID: 33051340.
- Barsoumian HB, Ramapriyan R, Younes AI, Caetano MS, Menon H, Comeaux NI, Cushman TR, Schoenhals JE, Cadena AP, Reilly TP, Chen D, Masrorpour F, Li A, Hong DS, Diab A, Nguyen QN, Glitza I, Ferrarotto R, Chun SG, Cortez MA, Welsh J. Low-dose radiation treatment enhances systemic antitumor immune responses by overcoming the inhibitory stroma. J Immunother Cancer 8(2), 2020. PMID: 33106386.
- Boyce-Fappiano D, Bathala TK, Ye R, Pasalic D, Gjyshi O, Pezzi TA, Noticewala SS, McGinnis GJ, Maroongroge S, Kuban DA, Nguyen QN, McGuire SE, Hoffman KE, Choi S, Tang C, Kudchadker RJ, Frank SJ. Predictors of urinary toxicity with MRI-assisted radiosurgery for low-dose-rate prostate brachytherapy. Brachytherapy 19(5):574-583, 2020. e-Pub 2020. PMID: 32682778.
- Harada K, Hwang H, Wang X, Abdelhakeem A, Iwatsuki M, Murphy MAB, Maru DM, Weston B, Lee JH, Rogers JE, Trail A, Shanbhag N, Zhao M, Bhutani MS, Nguyen QN, Swisher SG, Ikoma N, Das P, Hofstetter WL, Badgwell BD, Ajani JA. Brain metastases in patients with upper gastrointestinal cancer is associated with proximally located adenocarcinoma and lymph node metastases. Gastric Cancer 23(5):904-912, 2020. e-Pub 2020. PMID: 32347396.
- Abu-Gheida I, Bathala TK, Maldonado JA, Khan M, Anscher MS, Frank SJ, Choi S, Nguyen QN, Hoffman KE, McGuire SE, Kim M, Kuban DA, Aparicio A, Chapin BF, Tang C. Increased frequency of Mesorectal and Perirectal LN involvement in T4 Prostate Cancers. Int J Radiat Oncol Biol Phys 107(5):982-985, 2020. e-Pub 2020. PMID: 32353391.
- Pasalic D, Betancourt-Cuellar SL, Taku N, Ludmir EB, Lu Y, Allen PK, Tang C, Antonoff MB, Fuller CD, Rosenthal DI, Morrison WH, Phan J, Garden AS, Welsh JW, Chang JY, Liao Z, Erasmus JJ, Nguyen QN. Outcomes and toxicities following stereotactic ablative radiotherapy for pulmonary metastases in patients with primary head and neck cancer. Head Neck 42(8):1939-1953, 2020. e-Pub 2020. PMID: 32129548.
- Harada K, Wu CC, Wang X, Mizrak Kaya D, Amlashi FG, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JA. Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Ann Surg 272(2):311-318, 2020. PMID: 32675544.
- Mesko S, Ning MS, Lakomy D, Verma V, Chang JY, O'Reilly M, Jeter MD, Gandhi SJ, Lin SH, Nguyen QN, Liao Z, Welsh J, Chen AB, Hahn S, Gomez DR. Thoracic radiation oncology clinical trial accrual and reasons for non-enrollment: results of a large, prospective, multi-year analysis. Int J Radiat Oncol Biol Phys 107(5):897-908, 2020. e-Pub 2020. PMID: 32360653.
- Rajaram R, Correa AM, Xu T, Nguyen QN, Antonoff MB, Rice D, Mehran R, Roth J, Walsh G, Swisher S, Hofstetter WL, Vaporciyan A, Cascone T, Tsao AS, Papadimitrakopoulou VA, Gandhi S, Liao Z, Sepesi B. Locoregional Control, Overall Survival and Disease-Free Survival in Stage IIIA (N2) Non-Small Cell Lung Cancer – An Analysis of Resected and Unresected Patients. Clin Lung Cancer 21(4):e294-e301, 2020. e-Pub 2020. PMID: 32089476.
- Ning MS, McAleer MF, Jeter MD, Minsky BD, Ghafar RA, Robinson IJ, Nitsch PL, Zaebst DJ, Todd SE, Nguyen J, Lin SH, Liao Z, Lee P, Gunn GB, Klopp AH, Dabaja BS, Nguyen QN, Chronowski GM, Bloom ES, Koong AC, Das P. Mitigating the impact of COVID-19 on oncology: Clinical and operational lessons from a prospective radiation oncology cohort tested for COVID-19. Radiother Oncol 148:252-257. e-Pub 2020. PMID: 32474129.
- Noticewala SS, Koong AC, Bloom ES, Choi S, Chronowski G, Ghafar RA, Guadagnolo BA, Gunn GB, Klopp A, Lee P, Li J, Liao Z, Ludmir EB, McAleer MF, Nguyen QN, Ning MS, Robinson IJ, Rosenthal DI, Shah SJ, Woodward WA, Zaebst DJ, Dabaja BS, Das P. Radiation Oncology Strategies to Flatten the Curve During the Coronavirus Disease 2019 (COVID-19) Pandemic: Experience From a Large Tertiary Cancer Center. Adv Radiat Oncol 5(4):567-572, 2020. PMID: 32775771.
- Davis JW, Ward JF, Pisters LL, Reichard CA, Wang X, Achim MF, Kuban DA, Choi S, Logothetis CJ, Troncoso P, Madsen LT, Babaian RJ, Nguyen QN, Kim J. Determining Clinically-Based Factors Associated with Reclassification in the Pre-MRI Era using a Large Prospective Active Surveillance Cohort. Urology 138:91-97, 2020. e-Pub 2019. PMID: 31899230.
- Mitchell KG, Nelson DB, Corsini EM, Vaporciyan AA, Antonoff MB, Mehran RJ, Rice DC, Roth JA, Sepesi B, Walsh GL, Bhutani MS, Maru DM, Wu CC, Nguyen QN, Ajani JA, Swisher SG, Hofstetter WL. Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience. Dis Esophagus 33(3), 2020. e-Pub 2019. PMID: 31313820.
- Bagley AF, Anscher MS, Choi S, Frank SJ, Hoffman KE, Kuban DA, McGuire SE, Nguyen QN, Chapin B, Aparicio A, Pezzi TA, Smith GL, Smith BD, Hess K, Tang C. Association of Sociodemographic and Health-Related Factors With Receipt of Nondefinitive Therapy Among Younger Men With High-Risk Prostate Cancer. JAMA Netw Open 3(3):e201255, 2020. e-Pub 2020. PMID: 32191331.
- Wang Z, Chen M, Sun J, Jiang S, Wang L, Wang X, Sahoo N, Gunn GB, Frank SJ, Nguyen QN, Liao Z, Chang JY, Zhu XR, Zhang X. Lyman-Kutcher-Burman normal tissue complication probability modeling for radiation-induced esophagitis in non-small cell lung cancer patients receiving proton radiotherapy. Radiother Oncol 146:200-204. e-Pub 2020. PMID: 32220701.
- Pasalic D, Betancourt-Cuellar S, Taku N, Mesko S, Bagley A, Chance W, Allen P, Tang C, Antonoff M, Mehran R, Welsh, J, Liao ZX, Gomez D, Erasmus J, Nguyen QN. Stereotactic Ablative Radiation Therapy for Pulmonary Metastases: Improving Overall Survival and Identifying Subgroups at High Risk of Local Failure. Radiat & Oncol 145:178-185, 2020. PMID: 32044530.
- Welsh JW, Heymach JV, Chen D, Verma V, Cushman TR, Hess KR, Shroff G, Tang C, Skoulidis F, Jeter M, Menon H, Nguyen QN, Chang JY, Altan M, Papadimitrakopoulou VA, Simon GR, Raju U, Byers L, Glisson B. Phase I Trial of Pembrolizumab and Radiation Therapy after Induction Chemotherapy for Extensive-Stage Small Cell Lung Cancer. J Thorac Oncol 15(2):266-273, 2020. e-Pub 2019. PMID: 31605794.
- Lopez A, Harada K, Chen HC, Bhutani MS, Weston B, Lee JH, Maru DM, Chin FW, Rogers JE, Thomas I, Amlashi FG, Blum-Murphy MA, Rice DC, Zhao M, Hofstetter WL, Nguyen QN, Ajani JA. Taxane-based or platinum-based combination chemotherapy given concurrently with radiation followed by surgery resulting in high cure rates in esophageal cancer patients. Medicine (Baltimore) 99(9):e19295, 2020. PMID: 32118743.
- Tang C, Hoffman KE, Allen PK, Gabel M, Schreiber D, Choi S, Chapin BF, Nguyen QN, Davis JW, Corn P, Logothetis C, Ward J, Frank SJ, Navai N, McGuire SE, Anscher M, Pisters L, Pettaway CA, Kumar R, Linson P, Tripuraneni P, Tomaszewski JJ, Patel AB, Augspurger M, Kuban DA. Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends. Cancer 126(3):506-514, 2020. e-Pub 2019. PMID: 31742674.
- Mitchell KG, Nelson DB, Corsini EM, Correa AM, Erasmus JJ, Hofstetter WL, Mehran RJ, Roth JA, Sepesi B, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC, Nguyen QN, Antonoff MB. Surveillance after Treatment of Non-Small Cell Lung Cancer: A Call for Multidisciplinary Standardization. Innovations 15(1):57-65, 2020. e-Pub 2019. PMID: 31875755.
- Grant SR, Lei X, Smith BS, Smith GL, Surena M, Wood C, Karam, JA, Nguyen QN, Frank SJ, Anscher MS. Stereotactic Body Radiotherapy for the Definitive Treatment of Early Stage Kidney Cancer: A Survival Comparison with Surgery, Tumor Ablation, and Observation Advances in Radiation Oncology. Advances in Radiation Oncology 5(3):495-502, 2020. PMID: 32529146.
- Nelson, D, Tayob N, Nguyen QN, Erasmus JJ, Mitchell KG, Hofstetter WL, Sepesi B, Antonoff MB, Mehran RJ. Local Failure after Stereotactic Body Radiation Therapy or Wedge Resection for Colorectal Pulmonary Metastases. J Thoracic and Cardiovascular Surgery 158(4):1234-1241, 2019. e-Pub 2019. PMID: 31395367.
- Welsh J, Tang C, de Groot P, Naing A, Hess K, Heymach J, Papadimitrakopoulou V, Cushman T, Subbiah V, Chang J, Simon G, Ramapriyan R, Barsoumian H, Menon H, Cortez M, Massarelli E, Nguyen QN, Sharma P, Allison J, Diab A, Verma V, Raju U, Shaaban S, Dadu R, Cabanillas M, Wang K, Anderson C, Gomez D, Hahn S, Komaki R, Hong D. Phase II Trial of Ipilimumab with Stereotactic Radiation Therapy for Metastatic Disease: Outcomes, Toxicities, and Low-Dose Radiation-Related Abscopal Responses. Cancer Immunology Research 7(12):1903-1909. e-Pub 2019. PMID: 31658994.
- Menon H, Chen D, Ramapriyan R, Verma V, Barsoumian HB, Cushman TR, Younes AI, Cortez MA, Erasmus JJ, de Groot P, Carter BW, Hong DS, Glitza IC, Ferrarotto R, Altan M, Diab A, Chun SG, Heymach JV, Tang C, Nguyen QN, Welsh JW. Influence of low-dose radiation on abscopal responses in patients receiving high-dose radiation and immunotherapy. J Immunother Cancer 7(1):237, 2019. e-Pub 2019. PMID: 31484556.
- Caetano MS, Younes AI, Barsoumian HB, Quigley M, Menon H, Gao C, Spires TE, Reilly TP, Cadena AP, Cushman TR, Schoenhals JE, Li A, Nguyen QN, Cortez MA, Welsh JW. Triple Therapy with MerTK and PD1 Inhibition plus Radiotherapy Promotes Abscopal Antitumor Immune Responses. Clin Cancer Res 25(24):7576-7584. e-Pub 2019. PMID: 31540976.
- Chen D, Menon H, Verma V, Seyedin SN, Ajani JA, Hofstetter WL, Nguyen QN, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Barsoumian HB, Erasmus JJ, Lee JH, Bhutani MS, Hess KR, Minsky BD, Welsh JW. Results of a Phase 1/2 Trial of Chemoradiotherapy With Simultaneous Integrated Boost of Radiotherapy Dose in Unresectable Locally Advanced Esophageal Cancer. JAMA Oncol 5(11):1597-1604, 2019. e-Pub 2019. PMID: 31529018.
- Pasalic D, Kuban DA, Allen PK, Tang C, Mesko SM, Grant SR, Augustyn AA, Frank SJ, Choi S, Hoffman KE, Nguyen QN, McGuire SE, Pollack A, Anscher MS. Dose Escalation for Prostate Adenocarcinoma: A Long-Term Update on the Outcomes of a Phase III, Single Institution Randomized Clinical Trial. Int J Radiat Oncol Biol Phys 104(4):790-797, 2019. e-Pub 2019. PMID: 30836166.
- Simon G, DiNardo CD, Takahashi K, Cascone T, Powers C, Stevens R, Allen J, Antonoff MB, Gomez D, Keane P, Suarez Saiz F, Nguyen QN, Roarty E, Pierce S, Zhang J, Hardeman Barnhill E, Lakhani K, Shaw K, Smith B, Swisher S, High R, Futreal PA, Heymach J, Chin L. Applying Artificial Intelligence to Address the Knowledge Gaps in Cancer Care. Oncologist 24(6):772-782, 2019. e-Pub 2018. PMID: 30446581.
- Nguyen QN, Chun SG, Chow E, Komaki R, Liao Z, Zacharia R, Szeto BK, Welsh JW, Hahn SM, Fuller CD, Moon BS, Bird JE, Satcher R, Lin PP, Jeter M, O'Reilly MS, Lewis VO. Single-Fraction Stereotactic vs Conventional Multifraction Radiotherapy for Pain Relief in Patients With Predominantly Nonspine Bone Metastases: A Randomized Phase 2 Trial. JAMA Oncol 5(6):872-878, 2019. e-Pub 2019. PMID: 31021390.
- Elhammali A, Blanchard P, Yoder A, Liao Z, Zhang X, Ronald Zhu X, Allen PK, Jeter M, Welsh J, Nguyen QN. Clinical outcomes after intensity-modulated proton therapy with concurrent chemotherapy for inoperable non-small cell lung cancer. Radiother Oncol 136:136-142, 2019. e-Pub 2019. PMID: 31015115.
- Harada K, Wu CC, Wang X, Mizrak Kaya D, Amlashi FG, Iwatsuki M, Blum Murphy MA, Maru DM, Weston B, Lee JH, Rogers JE, Thomas I, Shanbhag N, Bhutani MS, Hofstetter WL, Nguyen QN, Ajani JA. Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation. Ann Surg. e-Pub 2019. PMID: 30720506.
- Niknam S, Barsoumian HB, Schoenhals JE, Jackson H, Yanamandra N, Caetano MS, Li A, Younes AI, Cadena AP, Cushman TR, Chang JY, Nguyen QN, Gomez DR, Diab A, Heymach JV, Hwu P, Cortez MA, Welsh JW. Radiation followed by OX40 stimulation drives local and abscopal antitumor effects in an anti-PD1-resistant lung tumor model. Clin Cancer Res 24(22):5735-5743, 2018. e-Pub 2018. PMID: 29784675.
- Hoffman KE, Voong KR, Levy LB, Allen PK, Choi S, Schlembach PJ, Lee AK, McGuire SE, Nguyen QN, Pugh TJ, Frank SJ, Kudchadker RJ, Du W, Kuban DA. Randomized Trial of Hypofractionated, Dose-Escalated, Intensity-Modulated Radiation Therapy (IMRT) Versus Conventionally Fractionated IMRT for Localized Prostate Cancer. J Clin Oncol 36(29):2943-2949, 2018. e-Pub 2018. PMID: 30106637.
- Brooks ED, Sun B, Feng L, Verma V, Zhao L, Gomez DR, Liao Z, Jeter M, O'Reilly M, Welsh JW, Nguyen QN, Erasmus JJ, Eapen G, Ahrar K, Antonoff MB, Hahn SM, Heymach JV, Rice DC, Chang JY. Association of Long-term Outcomes and Survival With Multidisciplinary Salvage Treatment for Local and Regional Recurrence After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer. JAMA Netw Open 1(4):e181390, 2018. e-Pub 2018. PMID: 30646121.
- Nantavithya C, Gomez DR, Wei X, Komaki R, Liao Z, Lin SH, Jeter M, Nguyen QN, Li H, Zhang X, Poenisch F, Zhu XR, Balter PA, Feng L, Choi NC, Mohan R, Chang JY. Phase 2 Study of Stereotactic Body Radiation Therapy and Stereotactic Body Proton Therapy for High-Risk, Medically Inoperable, Early-Stage Non-Small Cell Lung Cancer. Int J Radiat Oncol Biol Phys 101(3):558-563, 2018. e-Pub 2018. PMID: 29680255.
- Yang J, Xu T, Gomez D, Yuan X, Nguyen QN, Jeter M, Song Y, Komaki R, Hu Y, Hahn SM, Liao Z. Nomograms incorporating genetic variants in BMP/Smad4/Hamp pathway to predict disease outcomes after definitive radiotherapy for non-small cell lung cancer. Cancer Med 7(6):2247-2255, 2018. e-Pub 2018. PMID: 29745043.
- Pan HY, Jiang J, Hoffman KE, Tang C, Choi SL, Nguyen QN, Frank SJ, Anscher MS, Shih YT, Smith BD. Comparative Toxicities and Cost of Intensity-Modulated Radiotherapy, Proton Radiation, and Stereotactic Body Radiotherapy Among Younger Men With Prostate Cancer. J Clin Oncol 36(18):1823-1830, 2018. e-Pub 2018. PMID: 29561693.
- Blanchard P, Davis JW, Frank SJ, Kim J, Pettaway CA, Pugh TJ, Pisters LL, Ward JF, Choi S, Chapin BF, Hoffman K, Navai N, Achim M, McGuire SE, Matin SF, Nguyen QN, Mahmood U, Graber WJ, Chen HC, Wang X, Kuban DA. Quality of life after brachytherapy or bilateral nerve-sparing robot-assisted radical prostatectomy for prostate cancer: a prospective cohort. BJU Int 121(4):540-548, 2018. e-Pub 2017. PMID: 28941030.
- Lopez Guerra JL, Song YP, Nguyen QN, Gomez DR, Liao Z, Xu T. Functional Promotor rs-189037 variant of ATM is associated with decreasing lung diffusing capacity after irradiation for non-small cell lung cancer. Chronic Dis Transl Med 4(1):59-66, 2018. PMID: None.
- Lopez Guerra JL, Song YP, Nguyen QN, Gomez DR, Liao Z, Xu T. Functional promoter rs189037 variant of ATM is associated with decrease in lung diffusing capacity after irradiation for non-small-cell lung cancer. Chronic Dis Transl Med 4(1):59-66, 2018. PMID: 29756124.
- Jeter MD, Gomez D, Nguyen QN, Komaki R, Zhang X, Zhu X, O'Reilly M, Fossella FV, Xu T, Wei X, Wang H, Yang W, Tsao A, Mohan R, Liao Z. Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study. Int J Radiat Oncol Biol Phys 100(3):730-737, 2018. e-Pub 2017. PMID: 29248169.
- Zhou R, Xu T, Nguyen QN, Liu Y, Yang J, Komaki R, Gomez DR, Liao Z. Radiation Dose, Local Disease Progression, and Overall Survival in Patients With Inoperable Non-Small Cell Lung Cancer After Concurrent Chemoradiation Therapy. Int J Radiat Oncol Biol Phys 100(2):452-461, 2018. e-Pub 2017. PMID: 29174428.
- Hong J, Liao Z, Zhuang Y, Levy LB, Sheu T, Heymach JV, Nguyen QN, Xu T, Komaki R, Gomez DR. Prognostic Factors as a Function of Disease-free Interval After Definitive (Chemo)radiation for Non-Small Cell Lung Cancer Using Conditional Survival Analysis. Am J Clin Oncol 41(1):46-52, 2018. e-Pub 2015. PMID: 26535988.
- Ho JC, Nguyen QN, Li H, Allen PK, Zhang X, Liao Z, Zhu XR, Gomez D, Lin SH, Gillin M, Komaki R, Hahn S, Chang JY. Reirradiation of thoracic cancers with intensity modulated proton therapy. Pract Radiat Oncol 8(1):58-65, 2018. e-Pub 2017. PMID: 28867546.
- Amlashi FG, Wang X, Davila RE, Maru DM, Bhutani MS, Lee JH, Weston BR, Mizrak Kaya D, Vassilakopoulou M, Harada K, Blum Murphy MA, Rice DC, Hofstetter WL, Davila M, Nguyen QN, Ajani JA. Barrett's Esophagus after Bimodality Therapy in Patients with Esophageal Adenocarcinoma. Oncology 95(2):81-90, 2018. e-Pub 2018. PMID: 29843157.
- Holliday EB, Kuban DA, Levy LB, Bolukbasi Y, Master P, Choi S, Nguyen QN, McGuire SE, Mahmood U, Frank SJ, Hoffman KE. Select men benefit from androgen deprivation therapy delivered with salvage radiation therapy after prostatectomy. Prostate Cancer Prostatic Dis 20(4):389-394, 2017. e-Pub 2017. PMID: 28462945.
- Chun SG, Solberg TD, Grosshans DR, Nguyen QN, Simone CB, Mohan R, Liao Z, Hahn SM, Herman JM, Frank SJ. The Potential of Heavy-Ion Therapy to Improve Outcomes for Locally Advanced Non-Small Cell Lung Cancer. Front Oncol 7:201, 2017. e-Pub 2017. PMID: 28929085.
- Mizrak Kaya D, Dong X, Nogueras-González GM, Xu Y, Estrella JS, Harada K, Lopez A, Amlashi FG, Hofstetter WL, Maru DM, Nguyen QN, Lee JH, Weston B, Bhutani MS, Erasmus JJ, Thomas I, Rogers JE, Song S, Ajani JA. Post-trimodality expression levels of metadherin (MTDH) as a prognostic biomarker for esophageal adenocarcinoma patients. Med Oncol 34(8):135, 2017. e-Pub 2017. PMID: 28685276.
- Antonoff MB, Correa AM, Sepesi B, Nguyen QN, Walsh GL, Swisher SG, Vaporciyan AA, Mehran RJ, Hofstetter WL, Rice DC. Salvage pulmonary resection after stereotactic body radiotherapy: A feasible and safe option for local failure in selected patients. J Thorac Cardiovasc Surg 154(2):689-699, 2017. e-Pub 2017. PMID: 28495066.
- Yang J, Xu T, Gomez DR, Yuan X, Nguyen QN, Jeter M, Song Y, Hahn S, Liao Z. Polymorphisms in BMP2/BMP4, with estimates of mean lung dose, predict radiation pneumonitis among patients receiving definitive radiotherapy for non-small cell lung cancer. Oncotarget 8(26):43080-43090, 2017. PMID: 28574846.
- Yue J, McKeever M, Sio TT, Xu T, Huo J, Shi Q, Nguyen QN, Komaki R, Gomez DR, Pan T, Wang XS, Liao Z. Association of lung fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer. Clin Transl Radiat Oncol 4(None):1-7, 2017. PMID: 29594201.
- Chance WW, Nguyen QN, Mehran R, Welsh JW, Gomez DR, Balter P, Komaki R, Liao Z, Chang JY. Stereotactic ablative radiotherapy for adrenal gland metastases: factors influencing outcomes, patterns of failure, and dosimetric thresholds for toxicity. Pract Radiat Oncol 7(3):195-203, 2017. e-Pub 2016. PMID: 27743801.
- Yue J, McKeever M, Sio TT, Xu T, Huo J, Shi Q, Nguyen QN, Komaki R, Gomez DR, Pan T, Wang XS, Liao Z. Association of Lung Fluorodeoxyglucose uptake with radiation pneumonitis after concurrent chemoradiation for non-small cell lung cancer. Clin Transl Radiat Oncol 11(4):1-7, 2017. PMID: None.
- Reddy JP, Tang C, Shih T, Kim B, Kim C, Nguyen QN, Welsh J, Benveniste M, Zhang J, Liao Z, Gomez DR. Influence of Surveillance PET/CT on Detection of Early Recurrence After Definitive Radiation in Stage III Non-small-cell Lung Cancer. Clin Lung Cancer 18(2):141-148, 2017. e-Pub 2016. PMID: 27913215.
- Welsh JW, Seyedin SN, Allen PK, Hofstetter WL, Ajani JA, Chang JY, Gomez DR, Amini A, Swisher SG, Blum MA, Younes AI, Nguyen QN, Minsky BD, Erasmus JJ, Lee JH, Bhutani M, Komaki RU. Local Control and Toxicity of a Simultaneous Integrated Boost for Dose Escalation in Locally Advanced Esophageal Cancer: Interim Results from a Prospective Phase I/II Trial. J Thorac Oncol 12(2):375-382, 2017. e-Pub 2016. PMID: 27794500.
- Zhou R, Liao Z, Pan T, Milgrom SA, Pinnix CC, Shi A, Tang L, Yang J, Liu Y, Gomez D, Nguyen QN, Dabaja BS, Court L, Yang J. Cardiac atlas development and validation for automatic segmentation of cardiac substructures. Radiother Oncol 122(1):66-71, 2017. e-Pub 2016. PMID: 27939201.
- Liao L, Lim GJ, Li Y, Yu J, Sahoo N, Li H, Gillin M, Zhu XR, Mahajan A, Frank SJ, Grosshans DR, Nguyen QN, Gomez D, Zhang X. Robust Optimization for Intensity Modulated Proton Therapy plans with multi-isocenter large fields. International Journal of Particle Therapy 3(2):305-311, 2016. PMID: None.
- Li P, Wang X, Liu Z, Liu H, Xu T, Wang H, Gomez DR, Nguyen QN, Wang LE, Teng Y, Song Y, Komaki R, Welsh JW, Wei Q, Liao Z. Single Nucleotide Polymorphisms in CBLB, a Regulator of T-Cell Response, Predict Radiation Pneumonitis and Outcomes After Definitive Radiotherapy for Non-Small-Cell Lung Cancer. Clin Lung Cancer 17(4):253-262.e5, 2016. e-Pub 2015. PMID: 26732495.
- Pugh TJ, Choi S, Nogueras-Gonzalaez GM, Nguyen QN, Mahmood U, Frank SJ, Mathai B, Zhu XR, Sahoo N, Gillin M, Kuban DA, Hoffman KE, McGuire SE, Lee AK. Proton Beam Therapy for Localized Prostate Cancer: Results from a Prospective Quality-of-Life Trial. International Journal of Particle Therapy 3(1):27-36, 2016. PMID: None.
- Zhou R, Yang J, Pan T, Milgrom S, Pinnix C, Shi A, Yang J, Liu Y, Nguyen QN, Gomez D, Dabaja B, Balter P, Court L, Liao Z. SU-E-J-129: Atlas Development for Cardiac Automatic Contouring Using Multi-Atlas Segmentation. Med Phys 42(6):3294, 2015. PMID: 26127520.
- Nguyen QN, Ly NB, Komaki R, Levy LB, Gomez DR, Chang JY, Allen PK, Mehran RJ, Lu C, Gillin M, Liao Z, Cox JD. Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer. Radiother Oncol 115(3):367-72, 2015. e-Pub 2015. PMID: 26028228.
- Tang C, Gomez DR, Wang H, Levy LB, Zhuang Y, Xu T, Nguyen QN, Komaki R, Liao Z. Association between white blood cell count following radiation therapy with radiation pneumonitis in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 88(2):319-25, 2014. PMID: 24411603.
- Wang H, Liao Z, Zhuang Y, Xu T, Nguyen QN, Levy LB, O'Reilly M, Gold KA, Gomez DR. Do angiotensin-converting enzyme inhibitors reduce the risk of symptomatic radiation pneumonitis in patients with non-small cell lung cancer after definitive radiation therapy? Analysis of a single-institution database. Int J Radiat Oncol Biol Phys 87(5):1071-7, 2013. e-Pub 2013. PMID: 24161424.
- Pugh TJ, Munsell MF, Choi S, Nguyen QN, Mathai B, Zhu XR, Sahoo N, Gillin M, Johnson JL, Amos RA, Dong L, Mahmood U, Kuban DA, Frank SJ, Hoffman KE, McGuire SE, Lee AK. Quality of life and toxicity from passively scattered and spot-scanning proton beam therapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 87(5):946-53, 2013. e-Pub 2013. PMID: 24139077.
- Nguyen QN, Levy LB, Lee AK, Choi SS, Frank SJ, Pugh TJ, McGuire S, Hoffman K, Kuban DA. Long-term outcomes for men with high-risk prostate cancer treated definitively with external beam radiotherapy with or without androgen deprivation. Cancer 119(18):3265-71, 2013. e-Pub 2013. PMID: 23798338.
- Kim SH, Choi JB, Nguyen QN, Lee JM, Park S, Chung TD, Byun JY. Nanoporous platinum thin films synthesized by electrochemical dealloying for nonenzymatic glucose detection. Phys Chem Chem Phys 15(16):5782-7, 2013. e-Pub 2013. PMID: 23361231.
- Castle KO, Hoffman KE, Levy LB, Lee AK, Choi S, Nguyen QN, Frank SJ, Pugh TJ, McGuire SE, Kuban DA. Is androgen deprivation therapy necessary in all intermediate-risk prostate cancer patients treated in the dose escalation era?. Int J Radiat Oncol Biol Phys 85(3):693-9, 2013. e-Pub 2012. PMID: 22836052.
- McGuire SE, Lee AK, Cerne JZ, Munsell MF, Levy LB, Kudchadker RJ, Choi SL, Nguyen QN, Hoffman KE, Pugh TJ, Frank SJ, Corn PG, Logothetis CJ, Kuban DA. PSA Response to Neoadjuvant Androgen Deprivation Therapy Is a Strong Independent Predictor of Survival in High-Risk Prostate Cancer in the Dose-Escalated Radiation Therapy Era. Int J Radiat Oncol Biol Phys 85(1):e39-46, 2013. e-Pub 2012. PMID: 23102837.
- Bian SX, Kuban DA, Levy LB, Oh J, Castle KO, Pugh TJ, Choi S, McGuire SE, Nguyen QN, Frank SJ, Nguyen PL, Lee AK, Hoffman KE. Addition of short-term androgen deprivation therapy to dose-escalated radiation therapy improves failure-free survival for select men with intermediate-risk prostate cancer. Ann Oncol 23(9):2346-52, 2012. e-Pub 2012. PMID: 22357249.
- Sharp HJ, Swanson D, Pugh TJ, Kudchadker R, Kuban DA, Lee AK, Choi S, Nguyen QN, Hoffman K, McGuire S, Frank SJ. Screening colonoscopy before prostate cancer treatment can detect colorectal cancers in asymptomatic patients and reduce the rate of complications after brachytherapy. Practical Radiation Oncology 2(3):e7-e13, 2012. e-Pub 2012. PMID: 24674130.
- Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Prostate cancer-specific mortality after definitive radiation therapy: who dies of disease?. Eur J Cancer 48(11):1664-71, 2012. e-Pub 2012. PMID: 22336663.
- Vassiliev ON, Kudchadker RJ, Kuban DA, Frank SJ, Choi S, Nguyen QN, Lee AK. Dosimetric impact of fiducial markers in patients undergoing photon beam radiation therapy. Phys Med 28(3):240-4, 2012. e-Pub 2011. PMID: 21875820.
- Kim MM, Hoffman KE, Levy LB, Frank SJ, Pugh TJ, Choi S, Nguyen QN, McGuire SE, Lee AK, Kuban DA. Improvement in prostate cancer survival over time: a 20-year analysis. Cancer J 18(1):1-8, 2012. PMID: 22290249.
- Samuelian JM, Swanson DA, Kudchadker RJ, Pugh TJ, Kuban DA, Lee AK, Choi S, Nguyen QN, Bruno TL, Frank SJ. Long-term tumor control after brachytherapy for base-of-prostate cancer. J Contemp Brachytherapy 3(4):183-187, 2011. PMID: 23346126.
- Zhu XR, Poenisch F, Song X, Johnson JL, Ciangaru G, Taylor MB, Lii M, Martin C, Arjomandy B, Lee AK, Choi S, Nguyen QN, Gillin MT, Sahoo N. Patient-Specific Quality Assurance for Prostate Cancer Patients Receiving Spot Scanning Proton Therapy Using Single-Field Uniform Dose. Int J Radiat Oncol Biol Phys 81(2):552-9, 2011. e-Pub 2011. PMID: 21300457.
- Meyer J, Bluett J, Amos R, Levy L, Choi S, Nguyen QN, Zhu XR, Gillin M, Lee A. Spot Scanning Proton Beam Therapy for Prostate Cancer: Treatment Planning Technique and Analysis of Consequences of Rotational and Translational Alignment Errors. Int J Radiat Oncol Biol Phys 78(2):428-434, 2010. e-Pub 2010. PMID: 20100641.
- Nguyen QN, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, Chang EL. Management of Spinal Metastases from Renal Cell Carcinoma Using Stereotactic Body Radiotherapy. Int J Radiat Oncol Biol Phys 76(4):1185-92, 2010. e-Pub 2009. PMID: 19632064.
- Darus CJ, Callahan MB, Nguyen QN, Pastore LM, Schneider BF, Rice LW, Jazaeri AA. Chemoradiation with and without adjuvant extrafascial hysterectomy for IB2 cervical carcinoma. Int J Gynecol Cancer 18(4):730-5. e-Pub 2007. PMID: 17949426.
- Nguyen QN, Chang EL, Allen PK, Maor MH, Ater JL, Mahajan A, Wolff JE, Weinberg JS, Woo SY. Focal and craniospinal irradiation for patients with intracranial germinoma and patterns of failure. Cancer 107(9):2228-36, 2006. PMID: 17019739.
- Crane CH, Abbruzzese JL, Evans DB, Wolff RA, Ballo MT, Delclos M, Milas L, Mason K, Charnsangavej C, Pisters PW, Lee JE, Lenzi R, Vauthey JN, Wong AB, Phan T, Nguyen QN, Janjan NA. Is the therapeutic index better with gemcitabine-based chemoradiation than with 5-FU-based chemoradiation in locally advanced pancreatic cancer?. Int J Radiat Oncol Biol Phys 52(5):1293-1302, 2002. PMID: 11955742.
- Crane CH, Janjan NA, Evans DB, Wolff RA, Ballo MT, Milas L, Mason K, Charnsangavej C, Pisters PWT, Lee JE, Lenzi R, Vauthey NJ, Wong A, Phan T, Nguyen QN, Abbruzzese JL. Toxicity and efficacy of concurrent gemcitabine and radiotherapy for locally advanced pancreatic cancer. Int J Radiat Oncol Biol Phys 29(1):9-18, 2001. PMID: 11560155.
- Choi S, Buszek SM, Antonoff MB, Ward JF, Tang C, Nguyen QN, McGuire SE, Hoffman K, Frank SJ, Kuban DA, Anscher MS. Moderate Dose Salvage Radiotherapy with Concurrent Androgen Deprivation for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused Ultrasound. Urology. PMID: None.
- Xu T, Wu L, Gandhi S, Lin SH, Jing W, Nguyen QN, Chen A, Chang JY, Nurieva R, Sheshadri A, Altan M, Lee PP, Liao Z. Adjuvant Immune Checkpoint Inhibitor Immunotherapy, Treatment-Related Pulmonary Toxicity, and Survival in Locally Advanced Non-Small Cell Lung Cancer. J Thorac Oncol. PMID: None.
Invited Articles
- Nguyen QN, Choi S, Lee AK. Proton Therapy for the Treatment of Prostate Cancer. Prostate Cancer, 2011. PMID: None.
- Nguyen QN, Chang EL. Emerging role of proton beam radiation therapy for chordoma and chondrosarcoma of the skull base. Curr Oncol Rep 10(4):338-43, 2008. PMID: 18778560.
- Nguyen QN, Chang ELC. Advances in Treating Renal Cell Carcinoma. Duke CME Journal 1(3), 2008. PMID: None.
Manuals, Teaching Aids, Other Teaching Publications
- Nguyen QN. Medical Student Rotation Clerkship Guidelines for Radiation Oncology. None, 2014.
Other Articles
- Singh R, Valluri A, Lehrer EJ, Cao Y, Upadhyay R, Trifiletti DM, Lo SS, Redmond KJ, Sahgal A, Nguyen QN, Palmer JD Clinical outcomes following stereotactic body radiation therapy (SBRT) for Non-Spinal Bone Metastases: A Systematic Review and Meta-Analysis. Int J Radiat Oncol Biol Phys 119(4):1099-1109, 2024. PMID: 38220068.
- Marvaso G, Jereczek-Fossa BA, Zaffaroni M, Vincini MG, Corrao G, Andratschke N, Balagamwala EH, Bedke J, Blanck O, Capitanio U, Correa RJM, De Meerleer G, Franzese C, Gaeta A, Gandini S, Garibaldi C, Gerszten PC, Gillessen S, Grubb WR, Guckenberger M, Hannan R, Jhaveri PM, Josipovic M, Kerkmeijer LGW, Lehrer EJ, Lindskog M, Louie AV, Nguyen QN, Ost P, Palma DA, Procopio G, Rossi M, Staehler M, Tree AC, Tsang YM, Van As N, Zaorsky NG, Zilli T, Pasquier D, Siva S Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology. Lancet Oncol 25(5):e193-e204, 2024. PMID: 38697165.
- Wong HCY, Lee SF, Chan AW, Caini S, Hoskin P, Simone CB, Johnstone P, van der Linden Y, van der Velden JM, Martin E, Alcorn S, Johnstone C, Isabelle Choi J, Nader Marta G, Oldenburger E, Raman S, Rembielak A, Vassiliou V, Bonomo P, Nguyen QN, Chow E, Ryu S Stereotactic Body Radiation Therapy versus Conventional External Beam Radiotherapy for Spinal Metastases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Radiother Oncol 189:109914, 2023. PMID: 37739318.
- Betancourt Cuellar SL, Benveniste MF, Truong M, Nguyen QN, Atiyah A, Hofstetter WL, Erasmus JJ Liver Injury in Patients With Distal Esophageal Carcinoma After Precision Radiation Therapy: Systematic Review of FDG-PET/CT Patterns. Am J Clin Oncol 46(1):25-30, 2023. PMID: 36562692.
- Tang, C, Msaouel, P, Hara, K, Choi, H, Le, V, Shah, AY, Wang, J, Jonasch, E, Choi, S, Nguyen, QN, Das, P, Prajapati, S, Yu, ZH, Khan, K, Powell, SF, Murthy, R, Sircar, K, Tannir, NM Re. Urological Oncology: Adrenal, Renal, Ureteral and Retroperitoneal Tumors. J Urol 208(1):210-211, 2022. PMID: 35469446.
- Antonoff MB, Sofocleous CT, Callstrom MR, Nguyen QN The Roles of Surgery, Stereotactic Radiation, and Ablation for Treatment of Pulmonary Metastases. J Thorac Cardiovasc Surg 163(2):495-502, 2022. PMID: 33838914.
- Strange CD, Shroff GS, Truong MT, Nguyen QN, Vlahos I, Erasmus JJ Imaging of the post-radiation chest in lung cancer. Clin Radiol 77(1):19-30, 2022. PMID: 34090709.
- Sezen D, Verma V, He K, Abana CO, Barsoumian H, Ning MS, Tang C, Hurmuz P, Puebla-Osorio N, Chen D, Tendler I, Comeaux N, Nguyen QN, Chang JY, Welsh JW Considerations for Clinical Trials Testing Radiotherapy Combined With Immunotherapy for Metastatic Disease. Semin Radiat Oncol 31(3):217-226, 2021. PMID: 34090648.
- Menon H, Ramapriyan R, Cushman TR, Verma V, Kim HH, Schoenhals JE, Atalar C, Selek U, Chun SG, Chang JY, Barsoumian HB, Nguyen QN, Altan M, Cortez MA, Hahn SM, Welsh JW Role of Radiation Therapy in Modulation of the Tumor Stroma and Microenvironment. Front Immunol 10:193, 2019. PMID: 30828330.
- Nguyen QN Long-term Outcome for Inoperable NSCLC patients treated with Dose Escalated Definitive Proton Therapy with Chemotherapy. PTCOG, 2014. PMID: None.
- Shi A, Gomez D, Levy L, Liao ZX, Nguyen QN Initial Report of clinical Outcomes after Intensity-Modulated Radiation Therapy with Simultaneous Integrated Boost for Inoperable Non-Small Cell Lung Cancer. None. PMID: None.
- Liao Z, Pan T Milgrom S, Pinnix C, Liu Y, Gomez D, Nguyen QN, Dabaj B, Court L RO-D-16-00440R2. Radiotherapy and Oncology. PMID: None.
Abstracts
- Nguyen QN, Chun S, Chow E, Komaki R, Liao ZX, Fnu R, Szeto B, Welsh J, Hahn S, Fuller CD, Moon B, Bird J, Satcher R, Lin P, Jeter M, O’Reilly, Lewis V. Single-Fraction Stereotactic versus Conventional Multifraction Radiation for Non-Spinal Bone Metastases: A Randomized Phase II Trial. ASCO, Chicago, IL, 2019. PMID: None.
- Nguyen QN, Blanchard P, Komaki RU, Jeter MD, Gomez DR, Lu C, Zhu XR, Gillin MT, Ho JC, Chang JY, Hahn SM, Cox JD, Liao Z. Reported Outcomes and Toxicities for Inoperable, Stage II-III Non-Small Cell Lung Cancer Patients Treated with Concurrent Chemotherapy and Intensity Modulated Proton Therapy. ASTRO, San Diego, CA:E484-E485, 2017. PMID: None.
- Niknam S, Barsoumian H, Schoenhals J, Li A, Chang JY, Nguyen QN, Gomez DR, Heymach J, Cortez MA, Hwu P, Welsh, JW. Radiation Followed By an Anti-OX40 Immune Therapy Inhibits Anti-PD1-Resistant Tumors and Promotes Abscopal Effects. ASTRO, San Diego, CA, 2017. PMID: None.
- Nelson C, Chun SG, Spicer C, Bloom E, Chronowski GM, Nguyen QN, Kirsner SM. A Dosimetric Comparison of 3D-Conformal Arc Technique With Static AP/PA and Four Field Radiation Therapy for the Palliation of Spinal Metastases. ASTRO, San Diego, CA, 2017. PMID: None.
- Ning MS, Gunn GB, Palmer MB, Nguyen QN, Chang JY, Liao Z, Hahn SM, Frank SJ, Gomez DR. The Proton Insurance Approval Process for Thoracic Patients: Metrics and Access. ASTRO, San Diego, CA, 2017. PMID: None.
- Choi S, Blanchard P, Ye R, Lee AK, Nguyen QN, Pugh TJ, Zhu XR, Sahoo N, Frank SJ. Outcomes Following Proton Therapy for the Treatment of Prostate Cancer: Efficacy and Toxicity Results from 2 Prospective Single Institution Cohorts. ASTRO, San Diego, CA, 2017. PMID: None.
- Moreno AC, Zhang N, Giordano S, Komaki RU, Liao Z, Nguyen QN, Hofstetter W, Murphy MB, Lin SH. Comparative Effectiveness of Chemotherapy Alone Versus Chemotherapy and Radiation Therapy for Patients with Stage IV Esophageal Cancer. ASTRO, San Diego, CA, 2017. PMID: None.
- Geng H, Zhong H, Giaddui TG, Liao Z, Bradley JD, Gillin MT, Mohan R, Nguyen QN, Berman AT, Robinson CG, Hoppe BS, Willers H, Shepherd AF, Xiao Y, Presley J. Knowledge Engineering-Based Quality Evaluation of RTOG 1308 Proton Treatment plans. ASTRO, San Diego, CA, 2017. PMID: None.
- Moningi S, Kuban DA, Allen PK, Choi S, Frank SJ, Nguyen QN, McGuire SE, Skinner HD, Schlembach PJ, Voong R, Hoffman KE. Consideration of Patient Characteristics and Comorbidity in Selecting Candidates for Moderately Hypofractionated Radiation: Secondary Analysis From a Randomized Trial. ASTRO, San Diego, CA, 2017. PMID: None.
- Wei X, Allen PK, Liao Z, Lin SH, Skinner HD, Welsh JW, Gomez DR, Nguyen QN, Heymach J, Cox JD, Komaki RU. The Prognostic Factors of Lower Nadir of Neutrophil/Lymphocyte Ratio, Platelet/Lymphocyte Ratio Were Associated With Worse Treatment Outcomes in Patients With Limited-Stage Small Cell Lung Cancer. ASTRO, San Diego, CA, 2017. PMID: None.
- Nguyen QN, Lu Y, Tang C, Chance WW, Mehran R, Welsh JW, Jeter MD, Hahn SM, Balter P, Komaki RU, Gomez DR, Chang JY, Liao Z. Stereotactic Ablative Body Radiation for Pulmonary Metastases: Outcomes Based on Histology and Prognostic Factors. ASTRO, San Diego, CA, 2017. PMID: None.
- Ho JC, Nguyen QN, Li H, Allen PK, Zhang X, Zhu XR, Gomez DR, Lin SH, Gillin MT, Komaki RU, Liao Z, Hahn SM, Chang JY. Reirradiation of Thoracic Cancers with Intensity Modulated Proton Therapy. ASTRO Multidisciplinary Thoracic Cancers Symposium, San Francisco, CA, 2017. PMID: None.
- Lan M, Xu T, Gomez DR, Jeter MD, Nguyen QN, Deng W, Lin SH, Komaki RU, Liao Z. Association Between LGALS3 Gene Polymorphisms and Survival in Non-Small Cell Lung Cancer Patients Treated With Definitive Radiation Therapy. ASTRO Multidisciplinary Thoracic Cancers Symposium, San Francisco, CA, 2017. PMID: None.
- Nguyen QN, Lu Y, Tang C, Chance WW, Mehran R, Balter P, Welsh JW, Hahn SM, Jeter MD, Komaki RU, Gomez DR, Chang JY, Liao Z. Stereotactic Ablative Body Radiation for Pulmonary Metastases: Should We Consider Dose Escalation for More Unresponsive Histologies?. ASTRO Multidisciplinary Thoracic Cancers Symposium, San Francisco, CA, 2017. PMID: None.
- Hoffman KE, Voong KR, Levy LB, Pugh TJ, Choi S, Du W, Frank SJ, Johnson JL, Kudchadker R, Nguyen QN, Lee A, Mahmood U, McGuire SE, Kuban DA. Randomized Trial of Hypofractionated Dose-Escalated Intensity Modulated Radiation Therapy Versus Conventionally Fractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer. ASTRO, Boston, MA, 2016. PMID: None.
- Yue J, Jeter MD, Xu T, Huo J, Pan T, Nguyen QN, Komaki RU, Gomez DR, Liao Z. Lung Dosimetry, Radiation Pneumonitis, and FDG Uptake in Patients With Stage II-III Non-Small Cell Lung Cancer Treated With Passively Scattered Proton Therapy or Intensity Modulated Pho. ASTRO, Boston, MA, 2016. PMID: None.
- Lan M, Xu T, Yue J, Yang J, Gomez DR, Jeter MD, Nguyen QN, Shi Q, Hahn SM, Komaki RU, Wang X, Liao Z. Polymorphisms of BMP4 and HIF-1A Are Associated With Patient-Reported Symptoms in Non-Small-Cell Lung Cancer Patients Treated With Definitive Chemoradiation Therapy. ASTRO, Boston, MA, 2016. PMID: None.
- Choi S, Levy LB, Lee KK, Nguyen QN, Lee AK, McGuire SE, Kudchadker R, Du W, Hoffman KE, Mahmood U, Frank SJ, Kuban DA. Identifying a Subgroup of High-Risk Prostate Cancer Patients With Worse Clinical Outcomes: Should There Be a "Very High-Risk" Group?. ASTRO, Boston, MA, 2016. PMID: None.
- Blanchard P, Davis JW, Frank SJ, Jeri K, Pettaway CA, Pugh TJ, Pisters LL, Mahmood U, Ward JF, Choi S, Chapin BF, Hoffman KE, Navai N, McGuire SE, Matin SF, Nguyen QN, Thaker NG, Chen HC, Wang X, Kuban DA. How to Counsel Patients With Localized Prostate Cancer About Treatment Selection: Quality-of-Life Results of a Prospective Single-Institution Cohort. ASTRO, Boston, MA, 2016. PMID: None.
- Phan J, Frank SJ, Chun S, Zhu XR, Tung S, Wang C, Zhang X, Crawford C, Garden AS, Rosenthal DI, Gunn GB, Nguyen QN, Fuller CD, Wang H. Evaluation of Intensity Modulated Proton Therapy for Stereotactic Ablative Radiation Therapy of Recurrent Skull Base Tumors: A Comparative Treatment Planning Study With Volumetric Modulated Arc Therapy. ASTRO, Boston, MA, 2016. PMID: None.
- Nguyen QN. 5 Year Outcome for Inoperable NSCLC Stage II and III patients treated with Proton Therapy and Chemotherapy. ASTRO, San Francisco, CA, 2014. PMID: None.
- Nguyen QN. Predictive Factors and Outcome for Inoperable NSCLC patients treated with Dose escalated Proton Therapy Chemotherapy. ASTRO, Atlanta, GA, 2013. PMID: None.
- Nguyen QN. Comparison of 3D Conformal Therapy, Passive Scattering Proton Therapy and Active Scattering Proton Therapy in the treatment of Stage I Seminoma. ASTRO, Boston, MA, 2012. PMID: None.
- Nguyen QN. Utilizing a multi-field optimization intensity modulated proton technique (MFO-IMPT) to deliver a simultaneous integrated boost (SIB) to the dominant intraprostatic lesion for localized prostate cancer. ASTRO, Miami, FL, 2011. PMID: None.
- Nguyen QN. Factors predicting failure and prostate cancer mortality in high-risk prostate cancer patients treated with definitive external beam radiation therapy. ASTRO, San Diego, CA, 2010. PMID: None.
- Nguyen QN. Rectal sparing with utilization of an endo-rectal balloon for prostate patients treated with an IMRT technique. ARS Annual meeting, Cancun, Mexico, 2010. PMID: None.
- Nguyen QN, Levy L, Lee AK, Choi S, Frank SJ, Kuban DA. Long-term outcome of patients with high-risk prostate cancer treated definitively with external beam radiation therapy. ASTRO, Chicago, IL, 2009. PMID: None.
Book Chapters
- Erasmus, JJ, Nguyen, QN, Stewart, DJ, Swisher, SG. Lung Cancer. In: Oncologic Imaging: A Multidisciplinary Approach. Elsevier, 57-78, 2022.
- Nguyen QN, Gomez D, Komaki R, Liao Z. Intensity Modulated Radiation Therapy for Non-Small Cell Lung Cancer. In: Intensity-Modulated Radiation Therapy-Clinical Evidence and Techniques. None. None, 2014.
- Nguyen QN, Shiu A, Chang EL. Kilovoltage Computed Tomotherapy-Guided Stereotactic Body Radiotherapy in a patient with a solitary spinal metastasis using the Varian EXaCT CT-On Rails system. In: Image Guided Radiation Therapy, a Clinical Perspective. None. None, 2012.
- Nguyen QN, Shiu A, Chang EL. Spinal Tumors: Viewpoint-Fractionated Radiotherapy. In: Principles and Practice of Stereotactic Radiosurgery. None. None, 2012.
Grant & Contract Support
| Title: | MRI-Linac STereotactic AI-Enabled Radiotherapy with Bone Biomarker Integration to OperationAlize Rapid Delivery (MR-STARBOARD) |
| Funding Source: | NIH/NCI |
| Role: | PI |
Patient Reviews
CV information above last modified December 17, 2024